Rice Hall James & Associates LLC Takes $4.29 Million Position in Addus HomeCare Corporation $ADUS

Rice Hall James & Associates LLC acquired a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 42,704 shares of the company’s stock, valued at approximately $4,290,000. Rice Hall James & Associates LLC owned about 0.23% of Addus HomeCare as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of ADUS. TimesSquare Capital Management LLC acquired a new position in Addus HomeCare in the second quarter valued at approximately $31,502,000. Persistent Asset Partners Ltd acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $98,000. Bank of New York Mellon Corp acquired a new stake in shares of Addus HomeCare during the 2nd quarter worth approximately $11,219,000. State of Wyoming bought a new stake in shares of Addus HomeCare in the 2nd quarter worth approximately $79,000. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Addus HomeCare by 2.0% in the 2nd quarter. Assenagon Asset Management S.A. now owns 5,905 shares of the company’s stock worth $593,000 after purchasing an additional 114 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analysts Set New Price Targets

ADUS has been the subject of a number of recent research reports. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Barclays increased their price objective on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Finally, Citizens Jmp reissued a “market outperform” rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $130.88.

Addus HomeCare Stock Performance

ADUS stock opened at $114.90 on Tuesday. The company has a market capitalization of $2.15 billion, a P/E ratio of 20.16, a PEG ratio of 1.56 and a beta of 0.87. The company has a 50-day simple moving average of $107.32 and a 200 day simple moving average of $102.01. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.70 by $0.03. The firm had revenue of $377.41 million during the quarter, compared to analyst estimates of $376.24 million. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. Addus HomeCare’s revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.49 EPS. Sell-side analysts predict that Addus HomeCare Corporation will post 6.29 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.10% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.